Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Refractory epilepsy in adults].

J C Sánchez-Alvarez1, P Serrano-Castro, F Cañadillas-Hidalgo

  • 1Servicio de Neurología. Hospital Universitario Virgen de las Nieves, Granada, España. jucasan@infonegocio.com

Revista De Neurologia
|November 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Failure of an anti-CGRP monoclonal antibody in the treatment of migraine. Is it worthwhile trying another one?]

Revista de neurologia·2022
Same author

Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey.

Neurologia·2020
Same author

Validation of a short useful questionnaire in Spanish for the epidemiological screening of epilepsy in Spain. EPIBERIA Questionnaire.

Neurologia (Barcelona, Spain)·2012
Same author

Drug-resistant epilepsy: current recommendations for diagnosis and treatment in Spain.

Neurologia (Barcelona, Spain)·2011
Same author

Consensus-recommended diagnostic and therapeutic guidelines for drug-resistant epilepsy in Spain (Consenso RATE-España).

Neurologia (Barcelona, Spain)·2011
Same author

Treatment initiation in epilepsy: an expert consensus in Spain.

Epilepsy & behavior : E&B·2010
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

Epileptic seizures persist in 25-33% of patients despite treatment. New antiepileptic drugs (AEDs) and epilepsy surgery are crucial for managing refractory epilepsy and improving patient quality of life.

Area of Science:

  • Neurology
  • Epileptology

Context:

  • Refractory epilepsy affects 25-33% of patients inadequately managed with antiepileptic drugs (AEDs).
  • Understanding and managing drug-resistant epilepsy is critical due to its impact on daily life.

Purpose:

  • To define refractory epilepsy (RE) and outline diagnostic and therapeutic considerations.
  • To emphasize the role of epilepsy surgery and optimized long-term management for patients with RE.

Summary:

  • Refractory epilepsy is characterized by persistent seizures despite trials of two optimal antiepileptic drugs (AEDs) at maximum doses.
  • Excluding pseudorefractory conditions and confirming seizure activity are essential steps.
  • Epilepsy surgery offers an efficient and safe therapeutic option for indicated patients, aiming for early intervention.

Related Experiment Videos

  • Optimizing long-term therapy focuses on seizure reduction and minimizing AED toxicity to enhance quality of life.

    • Impact:

    • Highlights the need for novel therapeutic strategies to mitigate the irreversible consequences of uncontrolled epilepsy.
    • Underscores the importance of timely surgical evaluation for suitable candidates with refractory epilepsy.
    • Emphasizes a patient-centered approach to optimize quality of life in refractory epilepsy management.